Specialty code 183500000X · Vallejo, CA
NPI
1598031791
Since 2012
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
975 Sereno Dr
Vallejo, CA, 94589
Phone (707) 651-1000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.0M
2,800 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Kevin Ng prescribed most often to Medicare patients was Ozempic (Semaglutide), with 455 prescriptions and refills. In total Kevin Ng wrote 2,800 Medicare prescriptions that cost $1.0M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-04-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Ozempic Semaglutide | 455 | 476 | 100 | $338K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 320 | 946 | 168 | $7,398 |
| Victoza 2-Pak Liraglutide | 285 | 351 | 115 | $183K |
| Insulin Glargine-Yfgn Generic | 285 | 884 | 128 | $33K |
| Liraglutide Generic | 216 | 238 | 100 | $150K |
| Metformin Hcl Er Metformin Hcl | 192 | 640 | 99 | $1,828 |
| Jardiance Empagliflozin | 166 | 535 | 77 | $84K |
| Victoza 3-Pak Liraglutide | 144 | 150 | 42 | $113K |
| Humalog Kwikpen U-100 Insulin Lispro | 100 | 273 | 45 | $30K |
| Humulin 70/30 Kwikpen Insulin Nph Hum/Reg Insulin Hm | 85 | 217 | 35 | $17K |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 58 | 168 | 26 | $9,502 |
| Humulin N Insulin Nph Human Isophane | 49 | 131 | 27 | $6,564 |
| Glipizide Er Glipizide | 48 | 160 | 21 | $1,513 |
| Glimepiride Generic | 46 | 153 | 23 | $690 |
| Glipizide Generic | 45 | 144 | 31 | $985 |
Brand drugs: 1,971 claims; generic drugs: 412 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kevin Ng were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.